Your browser doesn't support javascript.
loading
Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials.
Mease, Philip J; Gladman, Dafna D; Gomez-Reino, Juan J; Hall, Stephen; Kavanaugh, Arthur; Lespessailles, Eric; Schett, Georg; Paris, Maria; Delev, Nikolay; Teng, Lichen; Wollenhaupt, Jürgen.
Afiliação
  • Mease PJ; Swedish Medical Center/Providence St. Joseph Health, Seattle, Washington and University of Washington School of Medicine, Seattle.
  • Gladman DD; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Gomez-Reino JJ; Fundación Dominguez, Hospital Clínico Universitario, Santiago, Spain.
  • Hall S; Monash University, Cabrini Health, Melbourne, Australia.
  • Kavanaugh A; University of California San Diego School of Medicine, La Jolla.
  • Lespessailles E; Regional Hospital, University of Orléans, Orléans, France.
  • Schett G; Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany und Universitätsklinikum Erlangen, Erlangen, Germany.
  • Paris M; Amgen Inc, Thousand Oaks, California.
  • Delev N; Celgene Corporation, Summit, New Jersey.
  • Teng L; Amgen Inc, Thousand Oaks, California.
  • Wollenhaupt J; Jürgen Wollenhaupt: Schön Klinik Hamburg Eilbek, Hamburg, Germany.
ACR Open Rheumatol ; 2(8): 459-470, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32710493

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: ACR Open Rheumatol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: ACR Open Rheumatol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos